BIND Therapeutics (BIND) Files Chapter 11 Bankruptcy - StreetInsider...
05/02/16
![]()
BIND Therapeutics (BIND) Files Chapter 11 Bankruptcy
StreetInsider.com
BIND Therapeutics, Inc. (NASDAQ: BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, today announced that it has elected to file a voluntary petition under Chapter 11 of the Bankruptcy Code in the ...
and more »
[more]
StreetInsider.com
BIND Therapeutics, Inc. (NASDAQ: BIND), a biotechnology company developing targeted and programmable therapeutics called ACCURINS®, today announced that it has elected to file a voluntary petition under Chapter 11 of the Bankruptcy Code in the ...
and more »
- Feeds Categories: